EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

A Mechanistic Model of rAAV Production in Synthetic Cell Lines

Prahalad Srinivasan iD, Han-Jung Kuo iD, Yu-Chieh Lin, Yen-An Lu, Wei-Shou Hu, Qi Zhang iD

Biotechnology and Bioengineering · 2026-06 · 123 (6) · 1684-1694

DOI: 10.1002/bit.70208 ↗

At a glance

Journal article in Biotechnology and Bioengineering, published online on 2026-04-16. Written by Prahalad Srinivasan and 5 co-authors. Institution: Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota, USA. Major MEDLINE topics: Dependovirus, Genetic Vectors, Models, Biological, Artificial Cells. 54 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Science Foundation, University of Minnesota.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The recombinant adeno‐associated virus (rAAV) is a widely used vector for gene therapy. Its manufacturing faces significant challenges in producing the large quantities of vectors needed for clinical applications and reducing empty particles. We have previously constructed synthetic cell lines that harbor all genes to enable scalable rAAV production. Through a series of design‐construct‐test cycles, productivity has increased to a level comparable to the traditional manufacturing method of triple plasmid transfection. In this work, we construct a mechanistic model of rAAV production in these synthetic cell lines to facilitate this design‐construct‐test cycle. The model was fit to the experimentally measured time profile of viral genome, transcripts, and proteins of viral components, capsid data, and packaged rAAV. The model recapitulates the trends in viral component dynamics with different inducer concentration time profiles, provides mechanistic insights into the effect of inducer profile on rAAV production, and predicts the effect of host cell genetic modifications. Finally, the model was used to optimize the inducer profile to increase vector genome production and full particle content in two separate cases. In both cases, the model‐prescribed inducer concentration profile was experimentally performed and had the same trend of shift in VG and full particle content.

Subjects

MeSH terms (MEDLINE)

DependovirusGenetic VectorsModels, BiologicalArtificial CellsHumansCell LineGenome, Viral

Author keywords

gene therapymechanistic modelingrecombinant adeno‐associated virussynthetic biologyviral vector manufacturing technology

Authors and institutions

  • Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota, USA.

ORCID profiles: Prahalad Srinivasan, Han-Jung Kuo, Qi Zhang

Funding

  • National Science Foundation
  • University of Minnesota

Cite

APA

Srinivasan, P., Kuo, H. J., Lin, Y. C., Lu, Y. A., Hu, W. S., & Zhang, Q. (2026). A Mechanistic Model of rAAV Production in Synthetic Cell Lines. Biotechnology and Bioengineering, 123(6), 1684-1694. https://doi.org/10.1002/bit.70208

Vancouver

Srinivasan P, Kuo HJ, Lin YC, Lu YA, Hu WS, Zhang Q. A Mechanistic Model of rAAV Production in Synthetic Cell Lines. Biotechnology and Bioengineering. 2026;123(6):1684-1694. doi:10.1002/bit.70208

BibTeX
@article{Srinivasan2026,
  author = {Srinivasan, Prahalad and Kuo, Han-Jung and Lin, Yu-Chieh and Lu, Yen-An and Hu, Wei-Shou and Zhang, Qi},
  title = {A Mechanistic Model of rAAV Production in Synthetic Cell Lines},
  journal = {Biotechnology and Bioengineering},
  year = {2026},
  volume = {123},
  number = {6},
  pages = {1684--1694},
  doi = {10.1002/bit.70208}
}
Start for free →